Literature DB >> 21971900

Bronchial provocation tests in clinical practice.

Marcos de Carvalho Borges1, Erica Ferraz, Elcio Oliveira Vianna.   

Abstract

Bronchial hyperresponsiveness, which consists of an exaggerated response of the airways to bronchoconstrictor stimuli, is one of the main characteristics of asthma, presented in nearly all asthmatic patients. Bronchial hyperresponsiveness may also be present in other diseases, such as allergic rhinitis, chronic obstructive pulmonary disease, cystic fibrosis, heart failure and respiratory infection, and with some medications, such as β-blockers. Bronchial provocation tests (also known as bronchial challenges) are used to evaluate bronchial responsiveness. These tests have become increasingly used over the last 20 years, with the development and validation of accurate, safe and reproducible tests, and with the publication of well-detailed protocols. Several stimuli can be used in a bronchial challenge, and they are classified as direct and indirect stimuli. There are many indications for a bronchial challenge. In this review, we discuss the main differences between direct and indirect stimuli, and the use of bronchial challenges in clinical practice, especially for confirming diagnoses of asthma, exercise-induced bronchoconstriction and cough-variant asthma, and for use among elite-level athletes.

Entities:  

Mesh:

Year:  2011        PMID: 21971900     DOI: 10.1590/s1516-31802011000400008

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  2 in total

1.  Pulmonology approach in the investigation of chronic unexplained dyspnea.

Authors:  Danilo Cortozi Berton; Nathalia Branco Schweitzer Mendes; Pedro Olivo-Neto; Igor Gorski Benedetto; Marcelo Basso Gazzana
Journal:  J Bras Pneumol       Date:  2021-02-08       Impact factor: 2.624

2.  Not all that wheezes is asthma!

Authors:  José Antônio Baddini Martinez
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.